Anti-CD47 antibody trial in advanced cancers shows treatment appears safe, well-tolerated Posted by Genevieve Klien in biotech/medical Mar 52019 An antibody against the “don’t eat me” signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned. Author Krista Conger Published on March 5, 2019 March 5, 2019. Read more
